| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/1992 | CA1299169C Steroids having a spiro cycle in position 17, their process and intermediaries,their use as medications and the pharmaceutical preparations containing such |
| 04/21/1992 | CA1299109C Cosmetic composition |
| 04/21/1992 | CA1299098C Alcohol-based antimicrobial compositions |
| 04/20/1992 | WO1992006687A1 Novel 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents |
| 04/20/1992 | CA2053721A1 Antiphlogistic analgesic cream composition |
| 04/20/1992 | CA2053465A1 Hydroxyquinolone derivatives |
| 04/20/1992 | CA2052946A1 Method for the preparation of 5,11-dihydro-6h-dipyrido ¬3,2-b:2', 3'-e| ¬1,4|diazepines |
| 04/20/1992 | CA2052942A1 Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof |
| 04/20/1992 | CA2052014A1 Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| 04/20/1992 | CA2028031A1 Aryloxy alcoyl benzens, process for the preparation thereof and pharmaceutical compositions comprizing them |
| 04/19/1992 | WO1992006675A1 Aerosol formulation comprising beclomethasone 17,21 dipropionate |
| 04/19/1992 | CA2053641A1 1,4-dideoxy-4-fluornojirimycin |
| 04/19/1992 | CA2053626A1 Heterocyclic compounds |
| 04/19/1992 | CA2053599A1 Benzoheterocyclylalkylaminoalkanediphosphonic acids |
| 04/19/1992 | CA2053512A1 Hydroxylated inhibitors of hiv reverse transcriptase |
| 04/19/1992 | CA2052760A1 1-(3,4-dihydro-2-oxo-1h-quinolina-6-yl)-2-[4-(2-phenylethyl )piperidin-1-yl] ethanol and -ethanone, their preparation and their therapeutic application |
| 04/18/1992 | WO1992006977A1 NOVEL p-SUBSTITUTED PHENYL 4-OXYBUTANE AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| 04/18/1992 | WO1992006703A1 Synthetic lung surfactant |
| 04/18/1992 | WO1992006689A1 USE OF ENDO-N-(8-METHYL-8-AZABICYCLO[3.2.1]oct-3-yl)-2,3-DIHYDRO-3,3DIMETHYLINDOLE-1-CARBOXAMIDE IN THE TREATMENT OF DEPENDENCE AND WITHDRAWAL SYNDROME |
| 04/18/1992 | CA2094157A1 Use of endo-n-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2, 3-dihydro-3,3 dimethylindole-1-carboxamide in the treatment of dependence and withdrawal syndrome |
| 04/18/1992 | CA2071911A1 P-substituted derivatives of phenyl 4-oxybutane amine, processes for preparation thereof, and pharmaceutical compositions holding same |
| 04/18/1992 | CA2053622A1 5-h benzodiazepine derivative, pharmaceutical compositions containing same and process for preparing them |
| 04/17/1992 | WO1992006963A1 Arylpyridazinones |
| 04/17/1992 | WO1992006956A1 Indenoindole compounds |
| 04/17/1992 | WO1992006726A1 Vitamin-mineral treatment methods and compositions |
| 04/17/1992 | CA2094127A1 Arylpyridazinones |
| 04/17/1992 | CA2094024A1 Indenoindole compounds |
| 04/17/1992 | CA2053148A1 Dihydropyrimidine derivatives |
| 04/17/1992 | CA2052797A1 Phenylpiperidylamines and drugs containing them |
| 04/17/1992 | CA2052796A1 Phenylpiperidinylamines and drugs containing these |
| 04/16/1992 | WO1992006954A2 Pyrrolidine dione derivatives |
| 04/16/1992 | WO1992006203A1 MUTANTS OF tPA WHICH ARE RESISTANT TO THEIR COGNATE SERPIN INHIBITOR |
| 04/16/1992 | WO1992006090A1 Epoxysuccinamic acid derivative |
| 04/16/1992 | WO1992006082A1 Piperazine derivatives |
| 04/16/1992 | WO1992006075A1 Anti-atherosclerotic aryl compounds |
| 04/16/1992 | WO1992005803A1 Self-assembling ion pair drugs |
| 04/16/1992 | WO1992005789A1 Eye drops for cataract |
| 04/16/1992 | WO1992005788A1 New phosphonate derivatives as lipase agents inhibiting |
| 04/16/1992 | WO1992005787A1 Drug therapy for alcohol abusers |
| 04/16/1992 | WO1992005785A1 Water soluble camptothecin analogues, processes and methods |
| 04/16/1992 | WO1992005784A1 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists |
| 04/16/1992 | WO1992005782A1 Use of thromboxane a2-receptor antagonists against proliferative alterations of the blood vessel walls |
| 04/16/1992 | WO1992005781A1 Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form |
| 04/16/1992 | WO1992005780A1 Beta-carotene and vitamin e therapy for inhibition of major vascular events |
| 04/16/1992 | WO1992005778A1 Ionically cross-linked polymeric microcapsules |
| 04/16/1992 | WO1992005770A1 Drug delivery vehicles suspended in nonaqueous perfluorinated carrier |
| 04/16/1992 | WO1992005768A1 Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen |
| 04/16/1992 | WO1992004015A3 Regulation of t-cell proliferation via a novel 5ht1a receptor |
| 04/16/1992 | WO1991008737A3 Pharmacologically active amide carboxylate derivatives |
| 04/16/1992 | DE4032187A1 New N-retinoyl-L-amino mercapto cpds. - for prevention and treatment of mucous membrane disorders, e.g. silicosis, chronic bronchitis, gastritis, duodenal ulcers etc. |
| 04/16/1992 | DE4032163A1 New S-retinoyl-L-amino-mercapto compounds - for prevention and treatment of mucous membrane disorders, e.g. silicosis, chronic bronchitis, gastritis, duodenal, etc. ulcers |
| 04/16/1992 | DE4031960A1 Herbal compsns. or topical treatment of psoriasis - based on greater celandine |
| 04/16/1992 | CA2093008A1 Beta-carotene and vitamin e therapy for inhibition of major vascular events |
| 04/16/1992 | CA2091566A1 Pyrrolidine dione derivatives |
| 04/16/1992 | CA2070173A1 Piperazine derivatives |
| 04/16/1992 | CA2053475A1 Quinazoline derivatives and their preparation |
| 04/16/1992 | CA2053432A1 5-beta and 13-beta-ivermectin monoglucopyranosides |
| 04/16/1992 | CA2053431A1 Avermectins are produced from known microorganisms |
| 04/16/1992 | CA2053418A1 Preparation of novel ivermectin compounds |
| 04/16/1992 | CA2052973A1 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 04/16/1992 | CA2052971A1 2-heteroarylphenyl-carbapenem antibacterial agents |
| 04/16/1992 | CA2045806A1 Anhydrous blends of parachlorometaxylenol in surfactant mixtures |
| 04/16/1992 | CA2027600A1 Lotion mixture and method of treating psoriasis |
| 04/15/1992 | EP0480906A2 Pharmaceutical preparation on basis of Lys-plasminogen |
| 04/15/1992 | EP0480901A1 Azido-substituted fatty acid analog enzyme substrates |
| 04/15/1992 | EP0480841A1 Disinfactant composition for the agro-alimentary industry and veterinary medicine |
| 04/15/1992 | EP0480794A1 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and therapeutic use |
| 04/15/1992 | EP0480745A2 Substituted dihydrothieno-thiophene-2-sulfonamides and dioxides thereof |
| 04/15/1992 | EP0480717A1 Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/15/1992 | EP0480716A1 Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/15/1992 | EP0480715A1 Intermediates for preparing 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents |
| 04/15/1992 | EP0480714A2 HIV protease inhibitors having symmetrical structure |
| 04/15/1992 | EP0480713A1 Nucleoside antiviral and immunomodulating agents |
| 04/15/1992 | EP0480712A1 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents |
| 04/15/1992 | EP0480711A1 Inhibitors of HIV protease |
| 04/15/1992 | EP0480708A2 Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/15/1992 | EP0480693A2 Avermectin degradation products and derivatives |
| 04/15/1992 | EP0480692A2 Substituted 4,5-dihydrothieno[2,3-b]thiophene-2-sulfonamides |
| 04/15/1992 | EP0480691A2 Combination therapy for peptic ulcer treatment |
| 04/15/1992 | EP0480690A1 Aqueous ophthalmic microemulsions of tepoxalin |
| 04/15/1992 | EP0480659A2 Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia |
| 04/15/1992 | EP0480641A1 Tricyclic heterocycles |
| 04/15/1992 | EP0480624A1 Inhibitors of HIV protease |
| 04/15/1992 | EP0480623A1 New halomacrolides and derivatives having immunosuppressive activity |
| 04/15/1992 | EP0480572A1 Use of vitamin D compounds for the manufacture of a cosmetic composition and use of it for improvements of skin conditions |
| 04/15/1992 | EP0480519A1 Solid lactulose |
| 04/15/1992 | EP0480458A2 Process for the preparation of pharmaceutical compositions containing Viminol useful in the treatment of drug dependences |
| 04/15/1992 | EP0480455A1 Optically active thienotriazolodiazepine compounds |
| 04/15/1992 | EP0480391A2 Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production |
| 04/15/1992 | EP0480338A1 Diterpene compound and process for producing the same |
| 04/15/1992 | EP0480315A2 Use of a retinoid |
| 04/15/1992 | EP0480258A2 Use of substituted 2-mercapto-nicotinic acid derivatives for combat against endoparasites, novel substituted 2-mercaptonicotinir acid derivatives and processes for their preparation |
| 04/15/1992 | EP0480257A2 Use of a potassium channel activator for pharmaceutical compositions useful in cardiopulmonary bypass and organ transplant |
| 04/15/1992 | EP0480241A1 3-Piperazino-sydnonimines, process for their preparation and their use |
| 04/15/1992 | EP0480215A1 New sulfonamides as antifungal agents |
| 04/15/1992 | EP0480204A1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor |
| 04/15/1992 | EP0480155A2 4-Substituted dihydropyrido (4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders |
| 04/15/1992 | EP0480152A1 KS-505 derivatives |
| 04/15/1992 | EP0480077A1 Process for obtaining carnosic acid |
| 04/15/1992 | EP0480054A1 Percutaneously absorbable composition of morphine hydrochloride |